Capital Fund Management (CFM)’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-101,482
Closed -$1.01M 2437
2025
Q3
$1.01M Sell
101,482
-66,726
-40% -$695K ﹤0.01% 2098
2025
Q2
$1.67M Buy
+168,208
New +$1.77M ﹤0.01% 1771
2024
Q4
Sell
-59,455
Closed -$662K 2078
2024
Q3
$662K Buy
+59,455
New +$655K ﹤0.01% 1790
2022
Q4
Sell
-50,011
Closed -$522K 1446
2022
Q3
$522K Sell
50,011
-96,970
-66% -$1.26M ﹤0.01% 1257
2022
Q2
$1.85M Buy
146,981
+123,226
+519% +$1.31M 0.02% 860
2022
Q1
$258K Buy
+23,755
New +$289K ﹤0.01% 1392

Other funds holding DVAX

Capital Fund Management (CFM)'s DVAX Position: Q4 2025 in Review

Capital Fund Management (CFM) sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 101,482 shares — an estimated $1.01M sold.

Capital Fund Management (CFM) first reported a position in DVAX in Q1 2022 and held it in 6 quarters. The position peaked at $1.85M in Q2 2022. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Capital Fund Management (CFM) reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 101,482 Dynavax Technologies shares in Q4 2025, an estimated $1.01M.
  • Capital Fund Management (CFM) first reported a position in Dynavax Technologies in Q1 2022 and held it in 6 quarters.
  • Capital Fund Management (CFM)'s Dynavax Technologies position peaked at $1.85M in Q2 2022.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2025, filed 17 Feb 2026.